Navigation Links
Genaera in Medical News

Xmark Comments on Genaera Cost-Saving Plan

RIDGEFIELD, Conn., May 9 /PRNewswire/ -- Xmark Opportunity Partners, LLC, the investment manager to Xmark Opportunity Fund, L.P., Xmark Opportunity Fund, Ltd. and Xmark JV Investment Partners, LLC, announced today that it fully supports the initiatives outlined in the press release issued by G...

DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller

...nce companies. Prior to joining DOR, he served in the senior financial roles for VioQuest Pharmaceuticals Inc., Micromet Inc., Cytogen Corporation and genaera Corporation, all publicly traded, R&D-focused companies in the biotechnology and specialty pharmaceuticals arenas. Mr. Schnittker also held manage...

Genaera Corporation Board of Directors Dissolves Corporation and Forms Liquidating Trust

...TH MEETING, Pa., June 12 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...fer of the Company's assets and liabilities to the genaera Liquidating Trust (the "Trust"). The Trust w...l interest ("Unit") in the Trust for each share of genaera common stock then held of record by such stockhold...

Genaera Corporation Announces Results of Special Meeting of Stockholders

...UTH MEETING, Pa., June 5 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...he Company (the "Plan of Dissolution). About genaera genaera Corporation has developed trodusquemine (MSI-1436)...

Genaera Corporation Announces Approval of Plan of Liquidation and Dissolution by Board of Directors

...H MEETING, Pa., April 28 /PRNewswire-FirstCall/ -- genaera Corporation (the "Company")(Nasdaq: GENR ) today...lso be obtained by directing a written request to: genaera Corporation, Attn: Secretary, 5110 Campus Drive, P...th respect to the Plan of Dissolution. About genaera ...

Genaera Corporation Implements Cash Conservation Plan

...H MEETING, Pa., March 30 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...dent and Chief Executive Officer of Genaera. genaera estimates that it will incur restructuring charges...h the reduction in force. As of December 31, 2008, genaera had cash, cash equivalents and short-term investme...

Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph

...TH MEETING, Pa., March 9 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced, in ...he Securities and Exchange Commission. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Corporation Announces 2008 Financial Results

...TH MEETING, Pa., March 3 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced its ...$8.1 million at December 31, 2008. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera to Present at BIO CEO & Investor Conference

...UTH MEETING, Pa., Feb. 5 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) will present at the ..., February 10, 2009 at 2:15 p.m. (ET). About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera to Participate in Obesity Panel at RBC Capital Markets Healthcare Conference

...UTH MEETING, Pa., Dec. 4 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that... www.wsw.com/webcast/rbc95/panel6 About genaera genaera Corporation is developing trodusquemine (MSI-1436)...
Genaera in Medical Technology

MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera

Broadens late-stage product development portfolio building on lead product candidate EcoNail in Phase 2 trial for onychomycosis WELLESLEY HILLS, Mass., Oct. 3 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTC Bulletin Board: MACM) today announced that it has exercised the option it ...

Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)

...TH MEETING, Pa., Feb. 10 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today reported promi...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia

... MEETING, Pa., Jan. 22 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced a po...metabolism and cholesterol elevation. About genaera genaera Corporation is developing trodusquemine (MSI-1436)...

Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics

...TH MEETING, Pa., Dec. 1 /PRNewswire-FirstCall/ -- genaera Corporation (Nasdaq: GENR ) today announced that...ekly subcutaneously administered formulation which genaera expects to utilize in Phase 2 clinical trials in t...bolism and cholesterol elevation. About genaera ...

Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an... phase 1 clinical testing in obesity. In addition, genaera has a value-driven, fully out-licensed partnership...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting

...pated in the Phase 1 clinical program of MSI-1436. genaera plans to conduct an ascending multiple-dose study ...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association

...olism and cholesterol elevation. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting

...y of Neuroscience by Mitchell F. Roitman, Ph.D., a genaera collaborator and investigator with the University ...ry R. Wolfe, Ph.D. from Genaera. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma

...e asthma and exercise-induced bronchoconstriction. genaera and MedImmune entered into a research collaboratio...t multiple sites throughout the U.S. and Canada. genaera also noted that MedImmune announced preliminary sa...he U.S. at $14 billion annually. About Genaera genaera Corporation is focused on advancing the science an...
Genaera in Biological News

Natural antibiotics yield secrets to atom-level imaging technique

...istry, the Medical School and the Biophysics Research Division, as well as collaborators in Canada, Japan, India and the U.S. pharmaceutical companies genaera Corporation and Eli Lilly and Company. Ramamoorthy was awarded support from the National Institutes of Health and the National Science Foundation, thr...
Genaera in Biological Technology

Genaera Receives Non-Compliance Notice from Nasdaq

...UTH MEETING, Pa., May 27 /PRNewswire-FirstCall/ -- genaera Corporation ("the Company") (Nasdaq: GENR ) toda...has received notification from Nasdaq stating that genaera is no longer in compliance with Nasdaq Marketplace...with Nasdaq's continued listing requirements. genaera previously announced on April 28, 2009 that its Bo...

Genaera to Present at BIO-Europe 2008

...overview on Tuesday, November 18, 2008 at 11:00 a.m. CET. About Genaera genaera Corporation is developing trodusquemine (MSI-1436) for type 2 diabetes and ...e to inaccurate assumptions, unknown risks, uncertainties or other factors. genaera does not intend (and it is not obligated) to publicly update, revise or cor...

Genaera Corporation Announces Second Quarter Financial Results

... $12.8 million at June 30, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Elects Paul K. Wotton to Board of Directors

...am very pleased to join Genaera's Board. I believe genaera has the opportunity to develop MSI-1436 as a novel...owing metabolic disease market." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera Corporation to Present at BIO Business Forum

...iego Convention Center, Room 30A About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces First Quarter Financial Results

...$17.1 million at March 31, 2008. About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation Announces 2007 Financial Results

... be a pivotal year for Genaera." About Genaera genaera Corporation is focused on advancing the science an...tly undergoing phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...be delayed or may not be successful; the risk that genaera may not obtain regulatory approval for its product...

Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference

...ing webcast at: http:/www.wsw.com/webcast/rbc84qpanel23 About Genaera genaera Corporation is focused on advancing the science and treatment of metabolic ...re program that is presently undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core program and the aggressive ...

Genaera Corporation Announces Third Quarter Financial Results

...estone targets to drive shareholder value." About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...

Genaera to Present at Biotech 2007 and BIO InvestorForum

...(5:00 PM ET) on Thursday, October 11, 2007. About genaera genaera Corporation is focused on advancing the science an...tly undergoing Phase 2 clinical testing in asthma. genaera is committed to directing resources to its core pr...
Other Tags
(Date:4/26/2015)... Lauderdale, FL (PRWEB) April 26, 2015 ... 1,200 pieces of medical equipment from hospitals, surgery centers ... types of equipment will be sold including radiology, surgery, ... The live auction will take place Tuesday, April 28th ... Fort Lauderdale warehouse located at 5025 North Hiatus Rd., ...
(Date:4/26/2015)... In an article published last month ... head-neck biomechanics occurring during the use of handheld electronic devices ... determine that use of a tablet increases mechanical demand on ... - more than when the neck is in a neutral ... but pointing out the potential hazards of overuse of mobile ...
(Date:4/26/2015)... April 26, 2015 MidSouth Pain ... throughout the Southeast. MidSouth Pain Treatment Center is a ... Cordova, Southaven, Oxford and Jackson, two ambulatory surgery centers ... the Southaven and Cordova locations. , Dr. Michael ... went into medicine to help people, and when I ...
(Date:4/25/2015)... Avid Collector Andrew Hawley from Vintage Rock ... Coliseum concert posters. The concert was held on 12 ... American Tour. , According to Hawley, “The poster ... Maryland. This poster blank was used to advertise the ... uses garish lettering and colors on this boxing style ...
(Date:4/25/2015)... Jersey (PRWEB) April 25, 2015 In ... aged twelve and above needed treatment for an ... to the Substance Abuse and Mental Health Services Administration’s ... 2011). Beyond these alarming numbers are harrowing stories of ... substance abuse . David H. Kerr , ...
Breaking Medicine News(10 mins):Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Growing Pains for MidSouth Pain Treatment Center 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
(Date:3/17/2015)... , March 17, 2015 ... company specializing in clinical study management systems, is ... in attendance at ARENA,s Outsourcing in Clinical Trials ... This event provides an excellent forum for MedNet ... flexible and affordable software-as-a-service (SaaS) eClinical technology platform. ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
Other Contents